AxoGen (AXGN)
NASDAQ:AXGN
Want to see AXGN full AI Analyst Report?
Total Valuation
AxoGen has a market cap or net worth of $2.18B. The enterprise value is $2.12B.
Market Cap$2.18B
Enterprise Value$2.12B
Share Statistics
AxoGen has 53,177,822 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,177,822
Owned by Insiders1.57%
Owned by Institutions19.25%
Financial Efficiency
AxoGen’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -3.91%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-3.91%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee499.35K
Profits Per Employee-34.82K
Employee Count451
Asset Turnover1.02
Inventory Turnover1.37
Valuation Ratios
The current PE Ratio of AxoGen is ―. AxoGen’s PEG ratio is -2.01.
PE Ratio―
PS Ratio6.69
PB Ratio11.70
Price to Fair Value11.70
Price to FCF-513.89
Price to Operating Cash Flow135.94
PEG Ratio-2.01
Income Statement
In the last 12 months, AxoGen had revenue of 225.21M and earned -15.70M in profits. Earnings per share was -0.34.
Revenue225.21M
Gross Profit167.35M
Operating Income-7.85M
Pretax Income-15.70M
Net Income-15.70M
EBITDA192.00K
Earnings Per Share (EPS)-0.34
Cash Flow
In the last 12 months, operating cash flow was 15.56M and capital expenditures -6.62M, giving a free cash flow of 8.93M billion.
Operating Cash Flow15.56M
Free Cash Flow8.93M
Free Cash Flow per Share0.17
Dividends & Yields
AxoGen pays an annual dividend of $1, resulting in a dividend yield of ―
Dividend Per Share$1
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.06
52-Week Price Change246.49%
50-Day Moving Average32.74
200-Day Moving Average24.42
Relative Strength Index (RSI)67.03
Average Volume (3m)801.93K
Important Dates
AxoGen upcoming earnings date is Aug 12, 2026, After Close (Confirmed).
Last Earnings DateApr 28, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
AxoGen as a current ratio of 5.11, with Debt / Equity ratio of 8.43%
Current Ratio5.11
Quick Ratio3.31
Debt to Market Cap0.01
Net Debt to EBITDA-84.93
Interest Coverage Ratio-1.02
Taxes
In the past 12 months, AxoGen has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AxoGen EV to EBITDA ratio is 7.77K, with an EV/FCF ratio of -508.33.
EV to Sales6.62
EV to EBITDA7.77K
EV to Free Cash Flow-508.33
EV to Operating Cash Flow1.84K
Balance Sheet
AxoGen has $82.65M in cash and marketable securities with $20.64M in debt, giving a net cash position of $62.01M billion.
Cash & Marketable Securities$82.65M
Total Debt$20.64M
Net Cash$62.01M
Net Cash Per Share$1.17
Tangible Book Value Per Share$2.65
Margins
Gross margin is 75.01%, with operating margin of -3.49%, and net profit margin of -6.97%.
Gross Margin75.01%
Operating Margin-3.49%
Pretax Margin-6.97%
Net Profit Margin-6.97%
EBITDA Margin0.09%
EBIT Margin-3.55%
Analyst Forecast
The average price target for AxoGen is $50.14, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$50.14
Price Target Upside30.24% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast22.41%
EPS Growth Forecast-292.36%